194 related articles for article (PubMed ID: 31052607)
1. Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors.
Romeo R; Iannazzo D; Veltri L; Gabriele B; Macchi B; Frezza C; Marino-Merlo F; Giofrè SV
Molecules; 2019 May; 24(9):. PubMed ID: 31052607
[TBL] [Abstract][Full Text] [Related]
2. 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.
Tang J; Maddali K; Dreis CD; Sham YY; Vince R; Pommier Y; Wang Z
Bioorg Med Chem Lett; 2011 Apr; 21(8):2400-2. PubMed ID: 21392991
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
[TBL] [Abstract][Full Text] [Related]
4. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors.
Čechová L; Dejmek M; Baszczyňski O; Šaman D; Gao L; Hu E; Stepan G; Jansa P; Janeba Z; Šimon P
Antivir Chem Chemother; 2019; 27():2040206619826265. PubMed ID: 30788976
[TBL] [Abstract][Full Text] [Related]
6. Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1.
Šimon P; Baszczyňski O; Šaman D; Stepan G; Hu E; Lansdon EB; Jansa P; Janeba Z
Eur J Med Chem; 2016 Oct; 122():185-195. PubMed ID: 27371922
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidine derivatives as potent human immunodeficiency virus-1 inhibitors.
Wang Z; Kang D; Chen M; Wu G; Feng D; Zhao T; Zhou Z; Huo Z; Jing L; Zuo X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Chem Biol Drug Des; 2018 Dec; 92(6):2009-2021. PubMed ID: 30079476
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitors.
Liu Y; Meng G; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
Eur J Pharm Sci; 2014 Oct; 62():334-41. PubMed ID: 24956462
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
[TBL] [Abstract][Full Text] [Related]
11. Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Ding L; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2020 Sep; 202():112549. PubMed ID: 32712537
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives.
Buemi MR; Gitto R; Ielo L; Pannecouque C; De Luca L
Bioorg Med Chem; 2020 Apr; 28(8):115431. PubMed ID: 32197813
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and antiviral evaluation of novel piperidine-substituted arylpyrimidines as HIV-1 NNRTIs by exploring the hydrophobic channel of NNIBP.
Zhang T; Zhou Z; Zalloum WA; Wang Z; Fu Z; Cherukupalli S; Feng D; Sun Y; Gao S; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
Bioorg Chem; 2021 Nov; 116():105353. PubMed ID: 34536931
[TBL] [Abstract][Full Text] [Related]
15. 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
Mai A; Artico M; Ragno R; Sbardella G; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; Maga G; La Colla P
Bioorg Med Chem; 2005 Mar; 13(6):2065-77. PubMed ID: 15727860
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
Ribone SR; Leen V; Madrid M; Dehaen W; Daelemans D; Pannecouque C; Briñón MC
Eur J Med Chem; 2012 Dec; 58():485-92. PubMed ID: 23159806
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Sang Y; Pannecouque C; De Clercq E; Zhuang C; Chen F
Bioorg Chem; 2020 Mar; 96():103595. PubMed ID: 32006797
[TBL] [Abstract][Full Text] [Related]
18. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
Jin X; Piao HR; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2021 Dec; 226():113868. PubMed ID: 34583311
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of piperidinyl-substituted [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potential anti-HIV-1 agents with reduced cytotoxicity.
Huang B; Kang D; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Chem Biol Drug Des; 2021 Jan; 97(1):67-76. PubMed ID: 32725669
[TBL] [Abstract][Full Text] [Related]
20. Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.
Manetti F; Esté JA; Clotet-Codina I; Armand-Ugón M; Maga G; Crespan E; Cancio R; Mugnaini C; Bernardini C; Togninelli A; Carmi C; Alongi M; Petricci E; Massa S; Corelli F; Botta M
J Med Chem; 2005 Dec; 48(25):8000-8. PubMed ID: 16335924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
